Articles
Living in a world of But’s

Living in a world of But’s

Social media is becoming increasingly popular and despite regulatory confinements, pharma companies are testing the waters and getting involved. Judith von Gordon explains how Boehringer Ingelheim is utilising social media channels and the challenges they have faced. Social Media is the brand of today’s generation, it has…

Articles
Pharma social media scan: the digital farrago

Pharma social media scan: the digital farrago

Emma D’Arcy begins her monthly round-up of the digital activity and the activities of the ‘digeratti’ in pharma. Welcome to my first column for pharmaphorum – where I’m looking forward to asserting an ‘erstwhile-expert’ view on the digital developments in pharma...

Articles
What Are IDEAs Made Of: The silo, 2

What Are IDEAs Made Of: The silo, 2

Mike Rea explores how decision making is optimised when teamwork and collaboration are in place. Pharma isn't predominantly a solo activity - it is team-based. However, increased 'silo-isation' (who said we couldn't verb words?) within the teams is producing significant challenge. There is an argument to be made that...

Sales & Marketing

Sales & Marketing
Solution Spotlight: BrandPRO Biopharma
Sponsored

Solution Spotlight: BrandPRO Biopharma

Strong strategy on paper can unravel when priorities collide. BrandPRO Biopharma gives pharmaceutical teams a place to put their decisions to the test

Digital

Market Access

Editor's Picks

  1. UK budget includes £1bn biopharma investment package
  2. HHS doubles down on controversial peptides plan
  3. Lilly's triple G overpowers Ozempic in diabetes trial
  4. UK puts £100m into "world-first" AI biosecurity facility
  5. US gives $99m for Ebola jab project, as cases spread in Africa

Newsletters and Deep Dive
digital magazine

Oncology

more

Patients

more

R&D

more